马来西亚 “安行证” 官方支付平台,提供为所有来自中国的留学生和旅客入境手续和新冠病毒COVID-19核酸检测,疫苗认证,健康码,检疫住宿安排指南等服务,自2021年1月1日起即刻生效 [5 Jan 2021]

新闻发布 马来西亚, 吉隆坡 / 中国,深圳市 (2020年12月31日) 讯: 马来西亚上市公司亿丰控股 Nexgram Holdings Berhad (“Nexgram”) 旗下子公司“泰巨科技” Tri-G Technologies Sdn Bhd (“Tri-G”) 以及“疫苗工坊” Vaccines Lab sdn Bhd (“VaccinesLab”) 今天与深圳万盛科咨询服务有限公司(“万盛科”)签署中国指定政府官方系统营运商合同(“ CHINA-PGSIC”),旨在于为所有来自中国的留学生和旅客提供一站式申请入境程序与支付服务, 方便申请 “特威乐” 安行证TRACVIRUS SafeTravelPass (STP) ,服务范围包括新冠病毒COVID-19核酸检测,疫苗认证,健康码,检疫住宿安排等,以及办理马来西亚移民厅旅游证 MyTravelPass 和外国公民入境签证 E-Visa/外劳EDS 等服务指南。为配合政府宣布于2021年1月1日重新接收外国学生,旅游安全通行证服务和政府同步开通服务。 “特威乐”门户网站为国际旅客(特别是重新入境马来西亚前已经在马来西亚学习的外国学生)提供在线入境签证程序指导和支付平台等服务。该支付平台目前为来自中国、台湾、新加坡、文莱、日本、韩国、新西兰和澳大利亚等 8 个国家和地区提供地方语言和电子支付便利。中国是第一个获得“特威乐”国际PGSIC合同的国家。 根据合同,”万盛科” 将整合、对接和开发符合地方本土化应用的支付系统,以满足中国政府和相关部门, 以及代理运营商等旅游操作需求,并以中国国内云数据服务商作为宗主国数据监督和托管中心, 以达到服务器分散式国际安全水平, 符合不同国家的个人隐私权和数据安全PDPA数据标准,目标每年至少代办200万来自中国的旅客,为期两(2)年,从2021年1月1日起生效。 迎合国际旅客出行需求, “万盛科”在中国稳步推广“安行证” SafeTravelPass后,将以中国作为出发点向中国邦交国统一推广“安行证”以及电子健康通行系统 “健康码”。 2019年,进入中国的国际入境人数约为1.4531亿人次; 国际旅客抵达马来西亚的人数约为2,610万人 ; 而根据统计报告,从中国到马来西亚的入境人数约为290万。 其中,大约有13,450名中国学生在马来西亚学习。 据《新海峡时报》报道,高级部长(安全组)拿督斯里·伊斯迈·萨比里 的报告指出从2021年1月1日开始通过私人教育机构录取的外国留学生,都获准进入马来西亚,从英国抵达的留学生除外。 入境的留学生必须遵守移民厅、国家安全委员会和国家灾害管理局制定准则和程序。只有已取得移民厅批准及签证的现有学生,才获准入境。 高级部长宣称 “入境留学生必须在出发前三天做新冠病毒Covid-19核酸检测,并在抵达我们的国际入境处再做一次检测”。 此前, 亿丰集团Nexgram已经和奥帝国有限公司OTTIGO Sdn Bhd签署政府系统运营商合同(PGSIC),旨在代表政府部门和关联机构, 包括 国家灾害管理局Agensi Pengurusan Bencana Negara(“ NADMA”)、移民厅、机场、新冠病毒Covid-19检测医护人员和专才,化验室、酒店和旅行社等机构, 辅助处理支付等系统开发,以提供马来西亚所有海关边界及机场的入境处实施办理旅客新冠病毒COVID-19核酸检测,疫苗认证,健康码,检疫住宿安排指南等服务。应用程式附带疫苗追踪系统, 全球连线, 方便通关认证。 迄今为止,该系统已开发了国际语言平台,包括英语、马来西亚语、简体中文、繁体中文、印尼语、韩语、日语和泰语,并备有本土化支付系统和数字健康码全球通行。 “特威乐” TRACVIRUS 开放式平台和各大国际电子商务平台相似,提供所有符合标准的运营商和相关机构注册和使用; 国家政府机构应用以免收费模式经营, 达到公平公正和人民利益为出发点。该平台的设计符合国家银行金融管制、反洗黑钱法令AMLA 和国际 ISO 20022 用户隐私和数据保护标准,并实施国际最高标准的数码安全系统保护用户医疗数据。该平台配备了人工智能 (”AI”)方程式模块,以达到机场或边境交通客流量分配的细化和顺畅化管理,旨在解决比如新冠病毒Covid-19客流量突发事故导致系统和资源瘫痪等瓶颈危机。Tracvirus提供有关当局和机场即时监控功能, 并防止当局陷入单一供应商垄断局面, 承担资源中断和设备感染等风险责任,其中高风险服务群包括支付平台供应商、医护人员和专才、化验室以及交通物流等其他服务。 该系统旨在依据遵守中国反垄断法和欧洲反垄断法规而设计,为各国国家安全管理局提供突发事件中央即时人流监控和操盘,为马来西亚的比如国家安全局 MKN、国家灾害管理局NADMA、移民厅和外交部KLN 等机构提供运营便利。 健康通行证或 “电子证书” 的数据化, 以及“安行证”  SafeTravelPass 的非接触模式,借助二维码系统, 提供各国政府合法授权的医护检测员和化验室以自行检测和化验方式操作,并向其客户和有关当局直接提交报告, 达到零肢体接触目标. 操作程序符合国际OAuth和ICAO NTWG DTC指南等国际标准, 辅助第一方处理客户个人医疗数据。这些版模可根据个别国家或地区机构的要求和标准进行特别定制,并可连接到每个国家独立的手机应用程序(比如马来西亚的MySejahtera)以后勤功能链接操作。 2020年11月4日亿丰集团Nexgram得到了国家安全局(”MKN”)有关“特威乐”Tracvirus电子健康检查系统接纳认可推荐书; 随后的国家灾害管理局Agensi Pengurusan Bencana Negara(”NADMA”)接纳认可推荐书; 以及由首相署至马来西亚机场控股公司的推荐信,以“加急”和“立刻执行”为由, 为边境开放提前做好准备。 “特威乐”Tracvirus 开放式平台和电子证书“E-Cert”于 2020 年 7 月份在马来西亚和印度尼西亚同步推出,随后为马来西亚入境旅客推出了 “特威乐” 安行证 TRACVIRUS SafeTravelPass (STP), 提供包括一站式新冠病毒COVID-19核酸检测,疫苗认证,健康码,检疫住宿安排等支付平台, 以及其他出行辅助和服务。 “特威乐”Tracvirus 是由亿丰集团 Nexgram 子公司美德氏信息技术有限公司 Medic Data Science(”MDS”) 所开发,由另一家连号子公司“泰巨科技”Tri-G Technologies Sdn Bhd 进行分销, 平台以开放式模式, 提供电子健康通行系统, 旨在辅助在新冠病毒Covid-19 突发期间出行者方便顺利入境马来西亚。平台的国际疫苗追踪系统是集团另一家子公司疫苗工坊Vaccines LabContinue reading “马来西亚 “安行证” 官方支付平台,提供为所有来自中国的留学生和旅客入境手续和新冠病毒COVID-19核酸检测,疫苗认证,健康码,检疫住宿安排指南等服务,自2021年1月1日起即刻生效 [5 Jan 2021]”

Malaysia SafeTravelPass for all China students and travelers payment facilitation of Covid-19 Screening Test, Vaccine Check, Digital Health Pass (E-Cert), Quarantine, Accommodation, MyTravelPass and E-Visa verification, effectively 1st January 2021. [5 Jan 2021]

MATERIAL PRESS RELEASE Kuala Lumpur, Malaysia / Shenzhen, China (December 31 2020):  Nexgram Holdings Berhad (“the Company” or “Nexgram”) subsidiary Tri-G Technologies Sdn Bhd (“Tri-G”) and Vaccines Lab sdn Bhd (“VaccinesLab”) today signed China Panel Government System Integrator Contract (“CHINA-PGSIC”) with Wan Sheng Ke Advisory Service Shenzhen Limited (“Wan  Sheng Ke”), dedicated to facilitate all China foreign students andContinue reading “Malaysia SafeTravelPass for all China students and travelers payment facilitation of Covid-19 Screening Test, Vaccine Check, Digital Health Pass (E-Cert), Quarantine, Accommodation, MyTravelPass and E-Visa verification, effectively 1st January 2021. [5 Jan 2021]”

Nexgram unit Vaccines Lab inks Joint Venture Agreement with Rafarma to distribute and manufacture Covid-19 vaccines in Indonesia and ASEAN [3 Dec 2020] News Coverage

3 December 2020 (Kuala Lumpur): U.S. public listed company Rafarma Pharmaceuticals, Inc. has signed a Joint Venture Agreement with Vaccines Lab Sdn Bhd, a subsidiary of Nexgram Biomedic Sdn Bhd, both wholly owned subsidiaries of Bursa Malaysia public listed Nexgram Holdings Berhad. Under the terms of the agreement, Rafarma and Vaccines Lab with create a newContinue reading “Nexgram unit Vaccines Lab inks Joint Venture Agreement with Rafarma to distribute and manufacture Covid-19 vaccines in Indonesia and ASEAN [3 Dec 2020] News Coverage”

Digital health passport SafeTravelPass begins International testing to help travel and trade resume [ 18 Nov 2020] Press Release

18 November 2020, Indonesia – SafeTravelPass allows travelers to record their COVID-19 status electronically and present it when they board a plane or cross a border. The digital health pass for travelers, SafeTravelPass, was launched in May 2020, and commenced in Malaysia and Indonesia in July 2020, will begin testing internationally today, Medic Data ScienceContinue reading “Digital health passport SafeTravelPass begins International testing to help travel and trade resume [ 18 Nov 2020] Press Release”

Malaysia “Tracvirus SafeTravelPass” System Integrator Contract awarded to OTTIGO by Nexgram units Tri-G and VaccinesLab to collect payment for government agencies for inbound travellers Covid-19 Screening Test, Quarantine, and Vaccine tracing. [11 Nov 2020] Press Release

MATERIAL PRESS RELEASE Kuala Lumpur, Malaysia (Nov 11 2020): Nexgram Holdings Berhad’s (“Nexgram”) sub- subsidiaries, Tri-G Technologies Sdn Bhd (“TRI-G”) and Vaccines Lab Sdn Bhd (“VaccinesLab”) awarded “Tracvirus SafeTravelPass” Panel Government System Integrator Contract (“PGSIC”) to OTTIGO Sdn Bhd which is developed to collect payment on behalf of Ministry of Health (“MOH”) for inbound travellers who conduct Covid-19 Screening Test, Quarantine,Continue reading “Malaysia “Tracvirus SafeTravelPass” System Integrator Contract awarded to OTTIGO by Nexgram units Tri-G and VaccinesLab to collect payment for government agencies for inbound travellers Covid-19 Screening Test, Quarantine, and Vaccine tracing. [11 Nov 2020] Press Release”

Nexgram inked letter of acceptance by MKN to use Tracvirus electronic health check system for inbound travellers for Ministry of Health (MOH) [5 Nov 2020] Material Press Release

MATERIAL PRESS RELEASE Kuala Lumpur, Malaysia (Nov 5): Nexgram Holdings Bhd (Nexgram) today secured National Security Council (MKN) acceptance for the use of Covid-19 electronic health check system for all nationwide borders, including inbound and outbound travellers. Nexgram new online platform called Tracvirus, developed by its subsidiary Medic Data Science Ltd, and distributed by anotherContinue reading “Nexgram inked letter of acceptance by MKN to use Tracvirus electronic health check system for inbound travellers for Ministry of Health (MOH) [5 Nov 2020] Material Press Release”

Mico BioMed RT-qPCR Covid-19 solution is ready for 1 million Indonesian labours through Medical Brands Inc. Nexgram Biomedic unit inked Strategic Cooperation Head of Agreement. [12 October 2020] Press Release.

PRESS RELEASE Kuala Lumpur, 28 October 2020 : Nexgram Biomedic unit Medical Brands Inc (MBI) inked Strategic Cooperation Head of Agreement (SCHOA) with Mcio BioMed Ltd (Mico BioMed) on 12 October, 2020, in mutual interest in an exclusive licensing agreement and/or forming a joint venture to (a) prepare On-Site solution for Covid-19 PCR test for MBIContinue reading “Mico BioMed RT-qPCR Covid-19 solution is ready for 1 million Indonesian labours through Medical Brands Inc. Nexgram Biomedic unit inked Strategic Cooperation Head of Agreement. [12 October 2020] Press Release.”

Fosun Malaysia COVID-19 PCR Distributor Nexgram received emergency use allocation to Malaysia. Supply to Sabah, Selangor, Negeri Sembilan and Pulau Pinang swab test secured. [8 October 2020] Press Release

SHANGHAI (Oct 8): Shanghai Fosun Long March medical Science Co, Ltd (Shanghai Fosun) PCR reagent received emergency use approval and increased supply to Malaysia through authorised distributor Tri-G Technologies, a subsidiary of Nexgram Holdings Bhd, in view of Malaysia rising cases nationwide including more cases in Sabah, Selangor, Negeri Sembilan and Pulau Pinang. Shanghai FosunContinue reading “Fosun Malaysia COVID-19 PCR Distributor Nexgram received emergency use allocation to Malaysia. Supply to Sabah, Selangor, Negeri Sembilan and Pulau Pinang swab test secured. [8 October 2020] Press Release”

Pemeriksaan Kesihatan Peringkat Awal Mampu Tangani Penularan Wabak [17 September 2020] News Report

/ Berita Terkini MAIPs / Khamis, 17 September 2020 15:48 KESEDARA untuk memastikan tahap kesihatan berada di tahap yang baik amat penting untuk diambil kira pada setiap masa terutama dalam situasa terkini untuk mengekang penularan wabak Covid-19 yang merisaukan seluruh rakyat Malaysia bahkan seluruh dunia. Malah kempen kesedaran perlu dipergiatkan untuk memastikan tahap kesihatan kita sentiasa berada dalamContinue reading “Pemeriksaan Kesihatan Peringkat Awal Mampu Tangani Penularan Wabak [17 September 2020] News Report”

Nexgram in RM118m partnership with Central Spine Road sub-contractor – [17 August 2020] The Edge

KUALA LUMPUR (Aug 17): Nexgram Holdings Bhd said today its wholly-owned unit Intra Binary Sdn Bhd (IBSB) is partnering Faldze Holdings Sdn Bhd (FHSB) for a sub-contract under the Central Spine Road project. The project — awarded to FHSB from main contractor Pembinaan Jaya Zira Sdn Bhd — is Section D, Package 3 of theContinue reading “Nexgram in RM118m partnership with Central Spine Road sub-contractor – [17 August 2020] The Edge”